Litcius/Paper detail

Use of a genetically engineered E. coli overexpressing β-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon carcinoma in a mouse model

Amin Afkhami-Poostchi, Mansour Mashreghi, Mehrdad Iranshahi, Maryam Moghaddam Matin

2020International Journal of Pharmaceutics48 citationsDOI

Topics & Concepts

Genetically engineeredColon carcinomaGenetically modified organismEscherichia coliChemistryInflammationPharmacologyCancer researchColorectal cancerBiologyBiochemistryMolecular biologyImmunologyGeneCancerGeneticsCancer Research and TreatmentsPharmacological Effects of Natural CompoundsBioactive Compounds and Antitumor Agents